FDA approves automated hepatitis B test

July 19, 2006

The U.S. Food and Drug Administration has approved the first automated product combining screening and confirmatory tests for hepatitis B surface antigen.

The Illinois-headquartered Abbott Laboratories' PRISM HBsAg assay was approved to test people who donate blood, blood components, and organs for the hepatitis B virus. The test also may be used to screen blood from cadavers for organ and tissue donation.

The FDA said the assay also was approved for the confirmation of samples it found to be reactive. Currently, screening and confirmatory tests are performed separately.

"This automated test system increases the efficiency and convenience of screening blood, tissue and organ donors for the hepatitis B virus," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "Improvements in blood donor screening and testing over the last few years have helped make the nation's blood supply safer from infectious diseases than it has been at any other time."

Hepatitis B, caused by a virus that infects the liver, can only be determined by a blood test.

Copyright 2006 by United Press International

Explore further: New hope for hepatitis C, an often hidden disease

Related Stories

New hope for hepatitis C, an often hidden disease

January 17, 2011

There's new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C - even though most who have the simmering infection don't know ...

IOM report recommends steps to tackle hepatitis B and C

January 11, 2010

Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed ...

New screening system for hepatitis C

February 11, 2010

A newly designed system of identifying molecules for treating hepatitis C should enable scientists to discover novel and effective therapies for the dangerous and difficult-to-cure disease of the liver, says Zhilei Chen, ...

Liver cancer marker could yield blood test for early detection

September 18, 2007

In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions. Due to widespread hepatitis B virus (HBV) infection, nearly 10 percent ...

Recommended for you

Turbulence in bacterial cultures

November 30, 2015

Turbulent flows surround us, from complex cloud formations to rapidly flowing rivers. Populations of motile bacteria in liquid media can also exhibit patterns of collective motion that resemble turbulent flows, provided the ...

Test racetrack dipole magnet produces record 16 tesla field

November 30, 2015

A new world record has been broken by the CERN magnet group when their racetrack test magnet produced a 16.2 tesla (16.2T) peak field – nearly twice that produced by the current LHC dipoles and the highest ever for a dipole ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.